756
Views
37
CrossRef citations to date
0
Altmetric
Research Article

Penetration enhancing effects of selected natural oils utilized in topical dosage forms

, , , &
Pages 2045-2054 | Received 29 Sep 2014, Accepted 25 Apr 2015, Published online: 10 Jul 2015

References

  • Joshi SC, Dut Jasuja N. Enhancement of transdermal delivery system and antidiabetic approach: an overview. Int J Pharm 2012;2:129–41
  • Rehman K, Zulfakar MH. Recent advances in gel technologies for topical and transdermal drug delivery. Drug Dev Ind Pharm 2014;40:433–40
  • Ruby PK, Pathak SM, Aggarwal D. Critical attributes of transdermal drug delivery systems (TDDS) – a generic product development review. Drug Dev Ind Pharm 2014;40:1421–8
  • Walters KA, Brain KR. Topical and transdermal delivery. In: Gibson M, ed. Pharmaceutical preformulation and formulation. 2nd edn. New York: Informa Healthcare; 2009:473–525
  • Barry BW. Transdermal drug delivery. In: Aulton ME, ed. Aulton’s pharmaceutics: the design and manufacture of medicines. 3rd edn. Edinburgh, Churchill Livingstone: Elsevier; 2007:565–97
  • Asbill CS, Michniak BB. Percutaneous penetration enhancers: local versus transdermal activity. PSTT 2000;3:36–41
  • Naik A, Kalia YN, Guy RH. Transdermal drug delivery: overcoming the skin’s barrier function. PSTT 2000;3:318–26
  • Sinha VR, Kaur MP. Permeation enhancers for transdermal drug delivery. Drug Dev Ind Pharm 2000;26:1131–40
  • Scheuplein RJ, Blank IH. Permeability of the skin. Physiol Rev 1971;51:702–47
  • López-Cervantes M, Márquez-Mejía E, Cázares-Delgadillo J, et al. Chemical enhancers for the absorption of substances through the skin: laurocapram and its derivatives. Drug Dev Ind Pharm 2006;32:267–86
  • Elias PM. Epidermal lipids, barrier function, and desquamation. J Invest Dermatol 1983;80:44–9
  • Elias PM. Lipids and the epidermal permeability barrier. Arch Dermatol Res 1981;270:95–117
  • Christophers E. Cellular architecture of the stratum corneum. J Invest Dermatol 1971;56:165–9
  • Quiñones OG, Mata dos Santos HA, Kibwila DM, et al. In vitro and in vivo influence of penetration enhancers in the topical application of celecoxib. Drug Dev Ind Pharm 2014;40:1180–9
  • Bonner MC, Barry BW. Vesicles under voltage. In: Smith EW, Maibach HI, eds. Percutaneous penetration enhancers. 2nd edn. Florida: CRC Press; 2006:257–68
  • Benson HAE. Transdermal drug delivery: penetration enhancement techniques. Curr Drug Deliv 2005;2:23–33
  • Foldvari M. Non-invasive administration of drugs through the skin: challenges in delivery system design. PSTT 2000;3:417–25
  • Rajadhyaksha VJ, Sharma K, Pfister WR. Oxazolidinones: a new class of permeation enhancer. In: Ghosh TK, Pfister WR, Yum SI, eds. Transdermal and topical drug delivery systems. Illinois: Interpharm Press; 1997:477–509
  • Barry BW. Dermatological formulations: percutaneous absorption. New York: Marcel Dekker; 1983
  • Patel NA, Patel NJ, Patel RP. Design and evaluation of transdermal drug delivery system for Curcumin as an anti-inflammatory drug. Drug Dev Ind Pharm 2009;35:234–42
  • Han F, Li S, Yin R, et al. Investigation of nanostructured lipid carriers for transdermal delivery of flurbiprofen. Drug Dev Ind Pharm 2008;34:453–8
  • Ben-Shabat S, Baruch N, Sintov AC. Conjugates of unsaturated fatty acids with propylene glycol as potentially less-irritant skin penetration enhancers. Drug Dev Ind Pharm 2007;33:1169–75
  • Zhang J, Purdon CH, Smith EW, et al. Penetration enhancement by skin hydration. In: Smith EW, Maibach HI, eds. Percutaneous penetration enhancers. 2nd edn. Florida: CRC Press; 2006:67–71
  • Finnin BC, Morgan TM. Transdermal penetration enhancers: applications, limitations, and potential. J Pharm Sci 1999;88:955–8
  • Charoo NA, Shamsher AAA, Kohli K, et al. Improvement in bioavailability of transdermally applied flurbiprofen using tulsi (Ocimum sanctum) and turpentine oil. Colloid Surf B 2008;45:300–7
  • Bigucci F, Abruzzo A, Cerchiara T, et al. Formulation of cellulose film containing permeation enhancers for prolonged delivery of propranolol hydrochloride. Drug Dev Ind Pharm 2014;11:1–9
  • Garrett RH, Grisham CM. Biochemistry. 4th edn. Boston: Brooks/Cole Cengage Learning; 2010
  • Fang J-Y, Chiu H-C, Wu J-T, et al. Fatty acids in Botryococcus braunii accelerate topical delivery of flurbiprofen into and across skin. Int J Pharm 2004;276:163–73
  • O’Brien RD. Fats and oils: formulating and processing for applications. 2nd edn. Florida: CRC Press; 2004:1–630
  • Büyüktimkin N, Büyüktimkin S, Rytting JH. Chemical means of drug permeation enhancement. In: Ghosh TK, Pfister WR, Yum SI, eds. Transdermal and topical drug delivery systems. Illinois: Interpharm Press; 1997:357–475
  • Mitsui T. New cosmetic science. Amsterdam: Elsevier Science; 1997
  • Lautenschläger H. Lipophilic substances – oils and lipids in cosmetic products. Kosmetik Int 2004;4:46–8
  • O’Brien RD. Fats and oils: formulating and processing for applications. 3rd edn. Florida: CRC Press; 2009
  • Heinrich M, Barnes J, Gibbons S, Williamson EM. Fundamentals of pharmacognosy and phytotherapy. Edinburgh: Churchill Livingstone Elsevier; 2004
  • Ojewole E, Kalhapure R, Akamanchi K, Govender T. Novel oleic acid derivatives enhance buccal permeation of didanosine. Drug Dev Ind Pharm 2014;40:657–68
  • Babu RJ, Singh M, Kanikkannan N. Fatty alcohols and fatty acids. In: Smith EW, Maibach HI, eds. Percutaneous penetration enhancers. 2nd edn. Florida: CRC Press; 2006:137–58
  • Kanikkannan N, Babu RJ, Singh M. Structure-activity relationship of chemical penetration enhancers. In: Smith, EW, Maibach HI, eds. Percutaneous penetration enhancers. 2nd edn. Florida: CRC Press; 2006:17–33
  • Williams AC, Barry BW. Penetration enhancers. Adv Drug Deliv Rev 2004;56:603–18
  • Naik A, Pechtold LARM, Potts RO, Guy RH. Mechanism of oleic acid-induced skin penetration enhancement in vivo in humans. J Control Release 1995;37:299–306
  • Shah VP. Skin penetration enhancers: scientific perspectives. In: Hsieh DS, ed. Drug permeation enhancement: theory and applications. New York: Marcel Dekker; 1994:19–23
  • Chi S-C, Park E-S, Kim H. Effect of penetration enhancers on flurbiprofen permeation through rat skin. Int J Pharm 1995;126:267–74
  • Santoyo S, Ygartua P. Effect of skin pretreatment with fatty acids on percutaneous absorption and skin retention of piroxicam after its topical application. Eur J Pharm Biopharm 2000;50:245–50
  • Craig PN. Drug compendium. In: Hansch C, Sammes PG, Taylor JB, eds. Comprehensive medicinal chemistry: the rational design, mechanistic study and therapeutic application of chemical compounds. Vol. 6. Oxford: Pergamon Press; 1990:1–541
  • Beaten V, Hourant P, Morales MT, Aparicio R. Oil and fat classification by FT-Raman spectroscopy. J Arg Food Chem 1998;46:2638–46
  • Butte W. Rapid method for the determination of fatty acid profiles from fats and oils using trimetylsulphonium hydroxide for transesterfication. J Chromatogr 1983;261:142–5
  • Kawadkar J, Pathak A, Kishore R, Chauhan MK. Formulation, characterization and in vitro-in vivo evaluation of flurbiprofen-loaded nanostructured lipid carriers for transdermal delivery. Drug Dev Ind Pharm 2013;39:569–78
  • González-Mira E, Nicolić S, García ML, et al. Potential use of nanostructured lipid carriers for topical delivery of flurbiprofen. J Pharm Sci 2011;100:242–51
  • Pellet MA, Roberts MS, Hadgraft J. Supersaturated solutions evaluated with an in vitro stratum corneum tape stripping technique. Int J Pharm 1997;151:91–8
  • Juneau P. Nonparametric methods in pharmaceutical statistics. In: Dmitrienko A, Chuang-Stein C, D’Agostino R, eds. Pharmaceutical statistics using SAS: a practical guide. North Carolina: SAS Press; 2007:117–51
  • Lang TA, Secic M. How to report statistics in medicine: annotated guidelines for authors, editors and reviewers. 2nd edn. Pennsylvania: Sheridan Press; 1997:1–365
  • Shimizu S, Nakano M. Molecular species of triacylglycerol isolated from depot fats of ratites. J Oleo Sci 2003;52:57–63
  • Kirschenbauer HG. Fats and oils: an outline of their chemistry and technology. 2nd edn. New York: Reinhold Publishing; 1960:1–240
  • Wiechers JW, Watkinson AC. The influence of formulation type on skin delivery. In: Wiechers JW, ed. Science and applications of skin delivery systems. Illinois: Allured Publishing Corporation; 2008:61–89
  • Hadgraft J, Finnin BC. Fundamentals of retarding penetration. In: Smith EW, Maibach HI, eds. Percutaneous penetration enhancers. 2nd edn. Florida: CRC Press; 2006:361–71
  • Wiechers JW. The influence of emollients on skin penetration from emulsions. In: Wiechers JW, ed. Science and applications of skin delivery systems. Illinois: Allured Publishing Corporation; 2008:91–108
  • Sallam MA, Motawaa AM, Mortada SM. An insight on human skin penetration of diflunisal: Lipogel versus hydrogel microemulsion. Drug Dev Ind Pharm 2015;41:141–7
  • Hafeez F, Chiang A, Hui X, Maibach H. Role of partition coeffiecients in determining the percutaneous penetration of salicylic acid and formaldehyde under varying occlusion durations. Drug Dev Ind Pharm 2014;40:1395–401
  • Ramchandani M, Toddywala R. Formulation of topical drug delivery systems. In: Ghosh TK, Pfister WR, Yum SI, eds. Transdermal and topical drug delivery systems. Illinois: Interpharm Press; 1997:539–67
  • Robinson DH, Narducci WA, Ueda CT. Drug delivery and administration. In: DiPiro JT, Talbert RL, Yee GC, Matzke GR, Wells BG, Posey LM, eds. Pharmacotherapy: a pathophysiological approach. 3rd edn. Connecticut: Appleton & Lange; 1997:49–76
  • Smith KL. Drug delivery and administration. In: Kemppainen BW, Reifenrath WG, eds. Methods for skin absorption. Florida: CRC Press; 1990:23–34
  • Fang J-Y, Hwang T-L, Fang C-L, Chiu H-C. In vitro and in vivo evaluations of efficacy and safety of skin permeation enhancers using flurbiprofen as a model drug. Int J Pharm 2003;255:153–66
  • Fang J-Y, Hwang T-L, Leu Y-L. Effect of enhancers and retarders on percutaneous absorption of flurbiprofen from hydrogels. Int J Pharm 2003;250:313–25
  • Ogiso T, Shintani M. Mechanism for the enhancement effect of fatty acids on the percutaneous absorption of propranolol. J Pharm Sci 1990;79:1065–71
  • Hadgraft J. Passive enhancement strategies in topical and transdermal drug delivery. Int J Pharm 1999;184:1–6
  • Wiechers JW. Skin delivery: what it is and why we need it. In: Wiechers JW, ed. Science and applications of skin delivery systems. Illinois: Allured Publishing Corporation; 2008:1–21
  • Katsuta Y, Lida T, Inomata D, Denda M. Unsaturated fatty acids induce calcium influx into keratinocytes and cause abnormal differentiation of epidermis. J Invest Dermatol 2005;124:1008–13
  • Tanojo H, Boelsma E, Junginger HE, et al. In vivo human skin permeability enhancement by oleic acid: a laser doppler velocimetry study. J Control Release 1999;58:97–104
  • Marjukka Suhonen T, Bouwstra JA, Urtti A. Chemical enhancement of percutaneous absorption in relation to stratum corneum structural alterations. J Control Release 1999;59:149–61
  • Thomas BJ, Finnin BC. The transdermal revolution. Drug Discov Today 2004;9:697–703
  • Leopold CS, Lippold BC. Enhancing effect of lipophilic vehicles on skin penetration of methyl nicotinate in vivo. J Pharm Sci 1995;84:195–7
  • El Magraby GM, Barry BW, Williams AC. Liposomes and skin: from drug delivery to model membranes. Eur J Pharm Sci 2008;34:203–22
  • Ghafourian T, Zandasrar P, Hamishekar H, Nokhodchi A. The effect of penetration enhancers on drug delivery through skin: a QSAR study. J Control Release 2004;99:113–25
  • Elyan BM, Sidhom MB, Plakogiannis FM. Evaluation of the effect of different fatty acids on the percutaneous absorption of metaproterenol sulphate. J Pharm Sci 1996;85:101–5
  • Komata Y, Kaneko A, Fujie T. Accumulation of lauric acid in skin as an enhancer for the percutaneous absorption of thiamine disulphide. Bio Pharm Bull 1995;18:791–3
  • Green PG, Guy RH, Hadgraft J. In vitro and in vivo enhancement of skin permeation with oleic and lauric acids. Int J Pharm 1988;48:103–13
  • Osthoff G, Hugo A, Bouwman H, Buss P, et al. Comparison of the lipid properties of captive, healthy wild, and pansteatitis-affected wild Nile crocodiles (Crocodylusniloticus). Comp Biochem Phys A 2010;155:64–9
  • Aungst BJ. Structure/effect studies of fatty acids isomers as skin penetration enhancers and skin irritants. Pharm Res 1989;3:244–7
  • Deng H, Tonojo H, Lenn J, Huang X. Foams as a novel vehicle in topical therapy. J Am Acad Dermatol 2004;50:80. doi: http://dx.doi.org/10.1016/j.jaad.2003.10.644
  • Nanayakkara GR, Bartlett A, Forbes B, et al. The effect of unsaturated fatty acids in benzyl alcohol on the percutaneous permeation of three model penetrants. Int J Pharm 2005;301:129–39
  • Kris-Etherton PM, Innis S. Position of the American dietetic association and dieticians of Canada: dietary fatty acids. J Am Diet Assoc 2007;107:1599–611

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.